Description:

RTOG 0825 Phase III GBM Follow-Up Form (F1) NCT00884741 Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=5A7D0D0E-5E03-3FE7-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=5A7D0D0E-5E03-3FE7-E044-0003BA3F9857

Keywords:
Versions (5) ▾
  1. 8/26/12
  2. 1/9/15
  3. 1/9/15
  4. 1/9/15
  5. 7/8/15
Uploaded on:

July 8, 2015

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

RTOG 0825 Phase III GBM Follow-Up Form (F1) NCT00884741

No Instruction available.

  1. StudyEvent: RTOG 0825 Phase III GBM Follow-Up Form (F1)
    1. No Instruction available.
RTOG clinical trial administrative data
Patient status assessment
Recurrence Or Progression
Non-protocol Therapy To Brain
seconds
seconds
seconds
Protocol Specific Adverse Event Evaluation
seconds
seconds
1000/uL
Protocol Specific Adverse Event Evaluation
Comments